封面
市场调查报告书
商品编码
1433605

大麻二酚市场规模、份额、趋势分析报告:按原料类型、销售类型、最终用途、地区和细分市场预测,2024-2030

Cannabidiol Market Size, Share & Trends Analysis Report By Source Type (Hemp, Marijuana), By Sales Type (B2B, B2C), By End-use (Medical, Personal Use), By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

大麻二酚市场成长与趋势:

Grand View Research, Inc. 的一项新研究显示,到 2030 年,全球大麻二酚市场规模预计将达到 220.5 亿美元。

预计2024年至2030年该市场将以15.8%的复合年增长率扩张。消费者对 CBD 产品态度的改变、公众舆论的变化以及对大麻二酚健康益处的认识不断提高是推动市场成长的一些关键因素。大麻植物含有 80 多种大麻Sativa,但大麻二酚是最广泛用于医疗目的的,因为它不具有精神活性。由于 CBD 含量高,它主要从大麻中提取。

各种注入 CBD 的产品需求量大,包括美容产品、大麻油、饮料、软糖和胶囊。 CBD可以透过多种方式进入人体,包括电子烟、吸烟和经皮。在大麻合法的美国,CBD被用来製造个人保健产品和医疗药品。大麻产品的合法化为各种最终用途产业扩大其产品供应创造了重大机会。

业界领先公司正专注于推出注入 CBD 的产品。随着全球对 CBD 需求的增加,企业正在国际市场上探索商机。此外,我们也投资于研发,以提高产品的有效性和效率并扩大我们的产品范围。厂商正在推出新的创新产品,例如食品、外用食品和饮料,以满足不断增长的需求。例如,2022年5月,Medical Marijuana, Inc.宣布在巴西推出一家名为「HM Pharma」的製药子公司,以扩大药局对CBD产品的取得。

大麻二酚市场报告亮点

  • 由于主要製造商的存在以及美国农业法案的核准是推动该地区成长的一些关键因素,北美在 2023 年占据了最大的市场占有率,达到 87.4%。
  • 由于其高纯度和潜在的健康益处,大麻衍生的 CBD 在 2023 年占据了市场占有率。
  • 到2023年,由于需求增加和使用大麻二酚作为原料的公司数量增加,B2B产业将占据最大的市场占有率。
  • 2023年,由于越来越多地将大麻衍生物用于各种医疗状况,製药领域在最终用途市场中占据最大的市场占有率。

目录

第一章 大麻二酚市场:调查方法与范围

第二章大麻二酚市场:执行摘要

  • 市场展望
  • 分部展望
  • 竞争考察

第三章 大麻二酚市场:变数、趋势、范围

  • 市场体系展望
  • 各国大麻监管情况
  • 市场动态
  • 大麻二酚市场分析工具
  • 按国家/地区分類的进出口情​​况

第四章 大麻二酚市场:原料类型预估及趋势分析

  • 2023 年及 2030 年按原料类型分類的市场占有率
  • 细分仪表板
  • 按成分类型分類的全球大麻二酚市场展望
  • 2018年至2030年市场规模、预测与趋势分析

第五章大麻二酚市场:销售类型估计与趋势分析

  • 2023 年及 2030 年销售类型市场占有率
  • 细分仪表板
  • 按销售类型分類的全球大麻二酚市场展望
  • 2018年至2030年市场规模、预测与趋势分析

第六章 大麻二酚市场:最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的全球大麻二酚市场展望
  • 2018年至2030年市场规模、预测与趋势分析

第七章 大麻二酚市场:区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 瑞士
    • 荷兰
    • 波兰
    • 捷克共和国
    • 克罗埃西亚
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 纽西兰
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 乌拉圭
    • 智利
  • 中东/非洲
    • 南非
    • 以色列

第八章 竞争形势

  • 最新趋势与影响分析:主要市场参与企业
  • 公司/竞争对手分类
  • 供应商形势
    • ENDOCA
    • Cannoid, LLC
    • Medical Marijuana, Inc.
    • Folium Europe BV
    • Canopy Growth Corporation
    • Elixinol
    • NuLeaf Naturals, LLC
    • Isodiol International, Inc.
    • PharmaHemp
    • The Cronos Group
Product Code: GVR-3-68038-122-1

Cannabidiol Market Growth & Trends:

The global cannabidiol market size is expected to reach USD 22.05 billion by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2024 to 2030. Changing consumer attitudes towards CBD products, shifting public opinion, and growing recognition of the health benefits of cannabidiol are some of the main factors contributing to the market's growth. The cannabis Sativa plant contains more than 80 cannabinoids, but cannabidiol is the most widely used for medical purposes because of its lack of psychoactive effects. It is primarily obtained from hemp due to its high CBD content.

There is a high demand for various CBD-infused products, such as beauty products, cannabis oil, beverages, gummies, capsules, etc. CBD can enter the human body through different means, including vaping, smoking, and through the skin. In the U.S., where cannabis is legal, CBD is utilized to produce personal care products and medical drugs. Legalizing cannabis-based products has opened up significant opportunities for various end-use industries to expand their product offerings.

Major players in the industry are focused on introducing CBD-infused products. Companies are exploring opportunities in international markets as the demand for CBD grows globally. Furthermore, they are investing in research and development to enhance the effectiveness and efficiency of their products, as well as to expand their offerings. The players are introducing new and innovative products, such as edibles, topicals, and beverages, to cater to the growing demand. For instance, in May 2022, Medical Marijuana, Inc. announced the launch of a pharma subsidiary in Brazil named "HM Pharma" to expand its access to CBD products in pharmacies.

Cannabidiol Market Report Highlights:

  • North America accounts for the largest with a market share of 87.4% in 2023 owing to the presence of major manufacturers, and approval of the U.S. Farm Bill are some of the major factors driving the growth of the region
  • Hemp-derived CBD dominated the market in 2023, with a market share owing to its higher purity and potential health benefits
  • B2B segment accounts for the largest market share in 2023 owing to increasing demand and a rising number of businesses using cannabidiol as raw materials
  • In 2023, the pharmaceuticals segment accounted for the largest market share in the end-use market owing to rising use of cannabis derivate for various medical conditions

Table of Contents

Chapter 1. Cannabidiol Market: Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Source type
    • 1.2.2. Sales type
    • 1.2.3. End use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Cannabidiol Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Source type outlook
    • 2.2.2. Sales type outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cannabidiol Market: Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Cannabis Regulatory Scenario, By Country
    • 3.2.1. U.S.
      • 3.2.1.1. Cultivation/Production
      • 3.2.1.2. Legal Status (CBD & THC)
      • 3.2.1.3. Regulatory Bodies Involved
    • 3.2.2. Canada
      • 3.2.2.1. Cultivation/Production
      • 3.2.2.2. Legal Status (CBD & THC)
      • 3.2.2.3. Regulatory Bodies Involved
    • 3.2.3. Germany
      • 3.2.3.1. Cultivation/Production
      • 3.2.3.2. Legal Status (CBD & THC)
      • 3.2.3.3. Regulatory Bodies Involved
    • 3.2.4. Italy
      • 3.2.4.1. Cultivation/Production
      • 3.2.4.2. Legal Status (CBD & THC)
      • 3.2.4.3. Regulatory Bodies Involved
    • 3.2.5. Croatia
      • 3.2.5.1. Cultivation/Production
      • 3.2.5.2. Legal Status (CBD & THC)
      • 3.2.5.3. Regulatory Bodies Involved
    • 3.2.6. Netherlands
      • 3.2.6.1. Cultivation/Production
      • 3.2.6.2. Legal Status (CBD & THC)
      • 3.2.6.3. Regulatory Bodies Involved
    • 3.2.7. Czech Republic
      • 3.2.7.1. Cultivation/Production
      • 3.2.7.2. Legal Status (CBD & THC)
      • 3.2.7.3. Regulatory Bodies Involved
    • 3.2.8. Poland
      • 3.2.8.1. Cultivation/Production
      • 3.2.8.2. Legal Status (CBD & THC)
      • 3.2.8.3. Regulatory Bodies Involved
    • 3.2.9. Switzerland
      • 3.2.9.1. Cultivation/Production
      • 3.2.9.2. Legal Status (CBD & THC)
      • 3.2.9.3. Regulatory Bodies Involved
    • 3.2.10. Australia
      • 3.2.10.1. Cultivation/Production
      • 3.2.10.2. Legal Status (CBD & THC)
      • 3.2.10.3. Regulatory Bodies Involved
    • 3.2.11. Israel
      • 3.2.11.1. Cultivation/Production
      • 3.2.11.2. Legal Status (CBD & THC)
      • 3.2.11.3. Regulatory Bodies Involved
    • 3.2.12. Uruguay
      • 3.2.12.1. Cultivation/Production
      • 3.2.12.2. Legal Status (CBD & THC)
      • 3.2.12.3. Regulatory Bodies Involved
    • 3.2.13. Colombia
      • 3.2.13.1. Cultivation/Production
      • 3.2.13.2. Legal Status (CBD & THC)
      • 3.2.13.3. Regulatory Bodies Involved
    • 3.2.14. Argentina
      • 3.2.14.1. Cultivation/Production
      • 3.2.14.2. Legal Status (CBD & THC)
      • 3.2.14.3. Regulatory Bodies Involved
    • 3.2.15. Chile
      • 3.2.15.1. Cultivation/Production
      • 3.2.15.2. Legal Status (CBD & THC)
      • 3.2.15.3. Regulatory Bodies Involved
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Cannabidiol Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
  • 3.5. Import/Export Scenario, by Country
    • 3.5.1. U.S.
    • 3.5.2. Canada
    • 3.5.3. Germany
    • 3.5.4. Italy
    • 3.5.5. France
    • 3.5.6. Croatia
    • 3.5.7. Netherlands
    • 3.5.8. Czech Republic
    • 3.5.9. Poland
    • 3.5.10. Switzerland
    • 3.5.11. Uruguay
    • 3.5.12. Columbia
    • 3.5.13. Brazil
    • 3.5.14. Argentina
    • 3.5.15. Chile
    • 3.5.16. Australia
    • 3.5.17. China
    • 3.5.18. India
    • 3.5.19. Japan
    • 3.5.20. New Zealand
    • 3.5.21. South Korea

Chapter 4. Cannabidiol Market: Source Type Estimates & Trend Analysis

  • 4.1. Source Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Cannabidiol Market by Source Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Hemp
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Marijuana
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cannabidiol Market: Sales Type Estimates & Trend Analysis

  • 5.1. Sales Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Cannabidiol Market by Sales Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Business to Business (B2B)
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Business to Consumer (B2C)
      • 5.4.2.1. Hospital Pharmacies
      • 5.4.2.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.2.2. Online Stores
      • 5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.2.3. Retail Stores
      • 5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cannabidiol Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Cannabidiol Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Medical
      • 6.4.1.1. Chronic Pain
      • 6.4.1.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.4.1.2. Mental Disorders
      • 6.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.4.1.3. Cancer
      • 6.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.4.1.4. Others
      • 6.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Personal Use
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Pharmaceutical
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Wellness
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.4.2. Food & Beverages
      • 6.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.4.4.3. Personal Care & Cosmetics
      • 6.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.4.4.4. Nutraceuticals
      • 6.4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.4.4.5. Others
      • 6.4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD million)

Chapter 7. Cannabidiol Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Switzerland
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. The Netherlands
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Poland
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Czech Republic
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.9. Croatia
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory framework
      • 7.6.9.3. Competitive Scenario
      • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. New Zealand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework
      • 7.7.6.3. Competitive Scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Colombia
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Uruguay
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive Scenario
      • 7.8.5.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.6. Chile
      • 7.8.6.1. Key country dynamics
      • 7.8.6.2. Regulatory framework
      • 7.8.6.3. Competitive Scenario
      • 7.8.6.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework
      • 7.9.1.3. Competitive Scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Israel
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. ENDOCA
      • 8.3.1.1. Company news
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Cannoid, LLC
      • 8.3.2.1. Company news
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Medical Marijuana, Inc.
      • 8.3.3.1. Company news
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Folium Europe B.V.
      • 8.3.4.1. Company news
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Canopy Growth Corporation
      • 8.3.5.1. Company news
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Elixinol
      • 8.3.6.1. Company news
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. NuLeaf Naturals, LLC
      • 8.3.7.1. Company news
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Isodiol International, Inc.
      • 8.3.8.1. Company news
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. PharmaHemp
      • 8.3.9.1. Company news
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. The Cronos Group
      • 8.3.10.1. Company news
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America cannabidiol market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 4 North America cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 5 North America cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 7 U.S. cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 8 U.S. cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 10 Canada cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 11 Canada cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe cannabidiol market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 14 Europe cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 15 Europe cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Germany cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 17 Germany cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 18 Germany cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 20 UK cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 21 UK cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 23 France cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 24 France cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 26 Italy cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 27 Italy cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Switzerland cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 29 Switzerland cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 30 Switzerland cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Poland cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 32 Poland cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 33 Poland cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 34 The Netherlands cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 35 The Netherlands cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 36 The Netherlands cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Czech Republic cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 38 Czech Republic cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 39 Czech Republic cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Croatia cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 41 Croatia cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 42 Croatia cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific cannabidiol market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 48 China cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 49 China cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Japan cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 51 Japan cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 52 Japan cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 54 India cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 55 India cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 57 South Korea cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 58 South Korea cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 60 Australia cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 61 Australia cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 62 New Zealand cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 63 New Zealand cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 64 New Zealand cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 66 Latin America cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 67 Latin America cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Brazil cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 69 Brazil cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 70 Brazil cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Mexico cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 72 Mexico cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 73 Mexico cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Argentina cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 75 Argentina cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 76 Argentina cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Colombia cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 78 Colombia cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 79 Colombia cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Uruguay cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 81 Uruguay cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 82 Uruguay cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Chile cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 84 Chile cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 85 Chile cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 86 MEA cannabidiol market, by region, 2018 - 2030 (USD Million)
  • Table 87 MEA cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 88 MEA cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 89 MEA cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 90 South Africa cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 91 South Africa cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 92 South Africa cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Israel cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 94 Israel cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 95 Israel cannabidiol market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cannabidiol market: market outlook
  • Fig. 9 Cannabidiol competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Cannabidiol market driver impact
  • Fig. 15 Cannabidiol market restraint impact
  • Fig. 16 Cannabidiol market strategic initiatives analysis
  • Fig. 17 Cannabidiol market: Source type movement analysis
  • Fig. 18 Cannabidiol market: Source type outlook and key takeaways
  • Fig. 19 Hemp market estimates and forecast, 2018 - 2030
  • Fig. 20 Marijuana market estimates and forecast, 2018 - 2030
  • Fig. 21 Cannabidiol Market: Sales type movement Analysis
  • Fig. 22 Cannabidiol market: Sales type outlook and key takeaways
  • Fig. 23 Business to Business (B2B) market estimates and forecasts, 2018 - 2030
  • Fig. 24 Business to Business (B2C) market estimates and forecasts,2018 - 2030
  • Fig. 25 Hospital pharmacies market estimates and forecasts,2018 - 2030
  • Fig. 26 Online stores market estimates and forecasts,2018 - 2030
  • Fig. 27 Retail pharmacies market estimates and forecasts,2018 - 2030
  • Fig. 28 Cannabidiol market: end use movement analysis
  • Fig. 29 Cannabidiol market: end use outlook and key takeaways
  • Fig. 30 Medical use market estimates and forecasts, 2018 - 2030
  • Fig. 31 Chronic pain market estimates and forecasts,2018 - 2030
  • Fig. 32 Mental disorders market estimates and forecasts, 2018 - 2030
  • Fig. 33 Cancer market estimates and forecasts,2018 - 2030
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030
  • Fig. 35 Personal use market estimates and forecasts,2018 - 2030
  • Fig. 36 Pharmaceutical CBD market estimates and forecasts,2018 - 2030
  • Fig. 37 Wellness market estimates and forecasts,2018 - 2030
  • Fig. 38 Food & beverages market estimates and forecasts,2018 - 2030
  • Fig. 39 Personal care & cosmetics market estimates and forecasts,2018 - 2030
  • Fig. 40 Nutraceuticals market estimates and forecasts,2018 - 2030
  • Fig. 41 Others end use market estimates and forecasts,2018 - 2030
  • Fig. 42 Global cannabidiol market: Regional movement analysis
  • Fig. 43 Global cannabidiol market: Regional outlook and key takeaways
  • Fig. 44 North America market estimates and forecasts, 2018 - 2030
  • Fig. 45 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 46 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 47 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030
  • Fig. 49 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 50 France market estimates and forecasts, 2018 - 2030
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 52 Switzerland market estimates and forecasts, 2018 - 2030
  • Fig. 53 Poland market estimates and forecasts, 2018 - 2030
  • Fig. 54 Czech Republic market estimates and forecasts, 2018 - 2030
  • Fig. 55 Croatia market estimates and forecasts, 2018 - 2030
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 57 China market estimates and forecasts, 2018 - 2030
  • Fig. 58 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 59 India market estimates and forecasts, 2018 - 2030
  • Fig. 60 New Zealand market estimates and forecasts, 2018 - 2030
  • Fig. 61 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 62 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 63 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 64 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 65 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 66 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 67 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 68 Uruguay market estimates and forecasts, 2018 - 2030
  • Fig. 69 Chile market estimates and forecasts, 2018 - 2030
  • Fig. 70 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 71 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 72 Israel market estimates and forecasts, 2018 - 2030